SUSAN HAMLIN: Open Payments
NPI 1366482515 · ST CHARLES, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$413 in 10 payments from 6 companies in 2025. Trend: 2023 $1,119 · 2024 $316 · 2025 $413
Food & beverage: $413
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 2 | $112 |
| AstraZeneca Pharmaceuticals LP | 1 | $98 |
| ADC THERAPEUTICS AMERICA, INC. | 1 | $92 |
| EMD Serono, Inc. | 4 | $78 |
| Novartis Pharmaceuticals Corporation | 1 | $19 |
| Merck Sharp & Dohme LLC | 1 | $14 |
Products named: Trodelvy, ZYNLONTA, PLUVICTO, KEYTRUDA.
Industry payments across MO — which companies pay providers there.
